Stryker Corporation $SYK Stock Bought by Segment Wealth Management LLC

Segment Wealth Management LLC increased its stake in Stryker Corporation (NYSE:SYK) by 5.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,971 shares of the medical technology company’s stock after buying an additional 3,198 shares during the quarter. Segment Wealth Management LLC’s holdings in Stryker were worth $16,515,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Gables Capital Management Inc. bought a new position in Stryker in the 2nd quarter valued at $25,000. Kilter Group LLC bought a new stake in shares of Stryker in the 2nd quarter valued at about $25,000. Cornerstone Financial Management LLC lifted its holdings in Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after buying an additional 31 shares during the period. Highland Investment Advisors LLC purchased a new stake in shares of Stryker during the 2nd quarter worth $25,000. Finally, Compass Financial Management LLC bought a new position in Stryker in the second quarter worth about $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Stock Performance

NYSE:SYK opened at $306.50 on Tuesday. The firm has a market capitalization of $117.56 billion, a price-to-earnings ratio of 31.76, a PEG ratio of 1.98 and a beta of 0.78. Stryker Corporation has a 1-year low of $267.00 and a 1-year high of $389.33. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The company’s 50-day moving average is $295.95 and its two-hundred day moving average is $326.09.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The company had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter last year, the firm earned $3.13 earnings per share. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts forecast that Stryker Corporation will post 14.93 EPS for the current year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 36.48%.

Analyst Ratings Changes

SYK has been the subject of a number of recent analyst reports. Truist Financial lowered their price objective on Stryker from $340.00 to $310.00 and set a “hold” rating for the company in a research report on Tuesday, October 6th. Citigroup decreased their price objective on Stryker from $399.00 to $360.00 and set a “buy” rating for the company in a report on Thursday, September 10th. BTIG Research lowered their price target on shares of Stryker from $358.00 to $316.00 and set a “buy” rating on the stock in a report on Monday, October 12th. Evercore set a $350.00 price objective on Stryker in a report on Monday, July 6th. Finally, Wells Fargo & Company cut their target price on shares of Stryker from $418.00 to $348.00 and set an “overweight” rating for the company in a research note on Wednesday, September 9th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $369.00.

Insider Activity

In related news, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Dylan Crotty sold 441 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 351,267 shares of company stock worth $118,197,701. 4.60% of the stock is currently owned by corporate insiders.

Stryker Company Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.